NEW YORK (GenomeWeb) – Weill Cornell Medicine announced today that it has received a $5 million gift to launch a new initiative that will accelerate and expand its use of precision medicine in patient care.

The gift was made by investment firm WorldQuant and its founder Igor Tulchinsky to support the creation of the WorldQuant Initiative for Quantitative Prediction, which aims to develop and use predictive tools and quantitative methods to better understand the genetic factors that drive disease in individual patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.